Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Income from Continuous Operations 2010-2025 | MKKGY

Merck annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Merck income from continuous operations for the quarter ending March 31, 2025 was $0.777B, a 2.45% increase year-over-year.
  • Merck income from continuous operations for the twelve months ending March 31, 2025 was $3.033B, a 2.22% increase year-over-year.
  • Merck annual income from continuous operations for 2024 was $3.015B, a 1.71% decline from 2023.
  • Merck annual income from continuous operations for 2023 was $3.067B, a 12.81% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $3.518B, a 2.98% decline from 2021.
  
Merck Annual Income from Continuous Operations
(Millions of US $)
2024 $3,015
2023 $3,067
2022 $3,518
2021 $3,626
2020 $2,278
2019 $1,452
2018 $1,291
2017 $2,950
2016 $1,807
2015 $1,241
2014 $2,240
2013 $2,535
2012 $2,125
2011 $1,948
2010 $839
2009 $536
Merck Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $777
2024-12-31 $711
2024-09-30 $893
2024-06-30 $652
2024-03-31 $759
2023-12-31 $633
2023-09-30 $805
2023-06-30 $770
2023-03-31 $859
2022-12-31 $667
2022-09-30 $933
2022-06-30 $926
2022-03-31 $992
2021-12-31 $923
2021-09-30 $901
2021-06-30 $900
2021-03-31 $902
2020-12-31 $512
2020-09-30 $942
2020-06-30 $318
2020-03-31 $505
2019-12-31 $375
2019-09-30 $377
2019-06-30 $473
2019-03-31 $226
2018-12-31 $204
2018-09-30 $376
2018-06-30 $291
2018-03-31 $420
2017-12-31 $1,165
2017-09-30 $763
2017-06-30 $465
2017-03-31 $557
2016-12-31 $285
2016-09-30 $513
2016-06-30 $355
2016-03-31 $654
2015-12-31 $138
2015-09-30 $407
2015-06-30 $380
2015-03-31 $321
2014-12-31 $313
2014-09-30 $331
2014-06-30 $405
2014-03-31 $446
2013-12-31 $382
2013-09-30 $450
2013-06-30 $419
2013-03-31 $345
2012-12-31 $350
2012-09-30 $232
2012-06-30 $-78
2012-03-31 $222
2011-12-31 $178
2011-09-30 $321
2011-06-30 $-124
2011-03-31 $466
2010-12-31 $89
2010-09-30 $272
2010-06-30 $224
2010-03-31 $255
2009-12-31 $107
2009-09-30 $206
2009-06-30 $148
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.685B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.420B 26.32
Zoetis (ZTS) United States $67.834B 24.61
Takeda Pharmaceutical (TAK) Japan $47.092B 9.61
Daiichi Sankyo, - (DSNKY) Japan $46.241B 23.70
BeOne Medicines - (ONC) Switzerland $33.942B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.788B 0.00
Summit Therapeutics (SMMT) United States $19.648B 0.00
Shionogi (SGIOY) Japan $15.142B 15.17
United Therapeutics (UTHR) United States $14.076B 12.18
Neurocrine Biosciences (NBIX) United States $13.024B 38.85
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.246B 0.00
Corcept Therapeutics (CORT) United States $7.587B 63.72
Grifols, S.A (GRFS) Spain $7.384B 0.00
Ionis Pharmaceuticals (IONS) United States $6.830B 0.00
Stevanato Group S.p.A (STVN) Italy $6.714B 39.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.111B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.949B 14.02
NewAmsterdam Pharma (NAMS) Netherlands $2.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.796B 0.00
Hypermarcas (HYPMY) Brazil $2.559B 19.24
Catalyst Pharmaceuticals (CPRX) United States $2.456B 8.23
Centessa Pharmaceuticals (CNTA) United Kingdom $2.365B 0.00
Ocular Therapeutix (OCUL) United States $2.201B 0.00
Dyne Therapeutics (DYN) United States $1.778B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.591B 23.71
Guardian Pharmacy Services (GRDN) United States $1.512B 0.00
Harrow (HROW) United States $1.480B 0.00
ARS Pharmaceuticals (SPRY) United States $1.430B 0.00
Ardelyx (ARDX) United States $1.407B 0.00
Evotec AG (EVO) Germany $1.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.311B 0.00
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Enliven Therapeutics (ELVN) United States $1.171B 0.00
Collegium Pharmaceutical (COLL) United States $1.171B 6.40
Cronos Group (CRON) Canada $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.872B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.750B 0.00
ProKidney (PROK) United States $0.708B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.680B 7.00
Theravance Biopharma (TBPH) United States $0.652B 53.92
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Siga Technologies (SIGA) United States $0.614B 7.59
Bioventus (BVS) United States $0.607B 14.68
Organogenesis (ORGO) United States $0.596B 0.00
Relay Therapeutics (RLAY) United States $0.584B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Elite Pharmaceuticals (ELTP) United States $0.567B 0.00
Oruka Therapeutics (ORKA) United States $0.562B 0.00
USANA Health Sciences (USNA) United States $0.558B 11.43
Xencor (XNCR) United States $0.546B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.522B 0.00
Savara (SVRA) United States $0.520B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Esperion Therapeutics (ESPR) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.353B 0.00
4D Molecular Therapeutics (FDMT) United States $0.332B 0.00
Altimmune (ALT) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.06
AleAnna (ANNA) United States $0.283B 0.00
OmniAb (OABI) United States $0.244B 0.00
Galectin Therapeutics (GALT) United States $0.238B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
Lyell Immunopharma (LYEL) United States $0.207B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Korro Bio (KRRO) United States $0.187B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.183B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
Liminatus Pharma (LIMN) United States $0.107B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Surrozen (SRZN) United States $0.093B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.063B 0.00
DURECT (DRRX) United States $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.18
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Ainos (AIMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.02
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00